Oklo
OKLO
$48.42
+14.77%
Oklo Inc. is a developer of advanced fission power plants, focusing on the commercialization of its liquid metal fast reactor technology through the Aurora powerhouse product line, which is designed to produce up to 15 megawatts of electricity using both recycled and fresh nuclear fuel. The company operates in the independent power producers industry, targeting clean, reliable, and affordable energy at scale, and also plans to offer used nuclear fuel recycling services to the U.S. market. As a pre-revenue, speculative player in the nuclear energy sector, Oklo has captured significant investor attention due to its inclusion in government initiatives like Project Prometheus and strategic partnerships, but it faces substantial regulatory and execution hurdles. The current investor narrative centers on the company's potential to disrupt the nuclear power landscape, with recent news highlighting both catalysts—such as DOE program selections and fuel supply agreements—and concerns over dilution and the long path to commercialization.…
OKLO
Oklo
$48.42
Related headlines
Investment Opinion: Should I buy OKLO Today?
Rating: Hold. Oklo is a speculative pre-revenue company with a consensus Buy rating and an average analyst target of $84.20, implying ~99.6% upside. However, the extreme valuation and lack of near-term revenue justify a cautious stance. The thesis hinges on successful commercialization of its Aurora reactor, which is years away and subject to regulatory and technical hurdles.
Sign up to view all
OKLO 12-Month Price Forecast
Oklo's forward-looking view is balanced between its strategic wins and severe financial challenges. The stock's valuation is not supported by current fundamentals, but the potential for disruptive nuclear technology and government backing provides upside optionality. I would upgrade to bullish if Oklo signs its first commercial customer or secures a major DOE contract, and downgrade to bearish if regulatory setbacks or significant dilution occur. The wide target range and high volatility warrant a cautious, event-driven approach.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $79.88 and implied upside of +65.0% versus the current price.
Average Target
$79.88
0 analysts
Implied Upside
+65.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$14 - $130
Analyst target range
Oklo is covered by 20 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 2.04 (where 1 is strong buy and 5 is sell), indicating a bullish stance. The average target price is $84.20, which implies an upside of approximately 99.6% from the current price of $42.19, suggesting that analysts see significant recovery potential. The target range is wide, from a low of $14.00 to a high of $130.00, reflecting high uncertainty about the company's future. The high target of $130 assumes successful commercialization and regulatory approvals, while the low target of $14 implies potential failure or severe dilution. Recent institutional ratings show a mix of Neutral and Buy/Outperform actions, with no recent downgrades, but the wide spread in targets and the speculative nature of the business suggest that investors should approach with caution.
Bulls vs Bears: OKLO Investment Factors
Oklo presents a classic high-risk, high-reward speculative investment. The bull case rests on strong analyst support, strategic government backing, and a solid cash position, while the bear case is driven by zero revenue, escalating losses, massive dilution, and an extreme valuation premium. Currently, the bearish evidence is more compelling given the lack of near-term revenue and the stock's persistent downtrend. The single most important tension is whether Oklo can convert its technological and regulatory progress into actual revenue and customer contracts before its cash runway depletes or investor patience runs out. If commercialization milestones are met, the stock could re-rate significantly; if not, further dilution and price declines are likely.
Bullish
- Analyst consensus Buy with 99.6% upside: 20 analysts rate OKLO a Buy with a mean score of 2.04, and the average target price of $84.20 implies ~99.6% upside from the current $42.19. This strong consensus reflects confidence in the company's long-term nuclear technology potential.
- Strategic government and fuel supply wins: Oklo was selected for Project Prometheus, a DOE program, and secured a long-term fuel supply agreement with Centrus Energy. These wins address critical fuel bottlenecks and validate the company's technology, providing tangible progress toward commercialization.
- Strong liquidity with $1.59B cash: As of Q1 2026, Oklo holds $1.59 billion in cash with a current ratio of 49.08, providing a substantial runway to fund operations and R&D. This financial buffer reduces near-term bankruptcy risk despite ongoing losses.
- Minimal debt burden: Debt-to-equity ratio is a mere 0.00098, indicating negligible leverage. This conservative capital structure limits financial distress risk and allows the company to focus on long-term development without debt repayment pressures.
Bearish
- Zero revenue and widening losses: Oklo reported $0 revenue in Q1 2026, with net loss expanding to -$33.06M from -$9.81M a year earlier. The company is pre-revenue and burning cash at an accelerating rate, with negative free cash flow of -$50.68M in the quarter.
- Massive dilution from stock issuance: In Q1 2026, Oklo issued $1.18 billion in common stock, increasing shares outstanding to 170.3M from 138.1M a year earlier. This dilution pressures existing shareholders and signals reliance on external financing to sustain operations.
- Extreme valuation premium: With a price-to-book ratio of 7.11 versus a utility sector average of 1-2x, Oklo trades at a substantial premium. This valuation implies high expectations for future growth that may not materialize, leaving little room for error.
- Steep price decline and negative momentum: The stock is down 49.2% over the past year and 40.7% over six months, with a max drawdown of -78.84%. Technical weakness and relative underperformance vs. the S&P 500 (relative strength -70.7% over 1Y) suggest persistent selling pressure.
OKLO Technical Analysis
Oklo's stock is in a pronounced downtrend, with a 1-year price change of -49.23% and a 6-month change of -40.66%, reflecting a sustained decline from its 52-week high of $193.84. The current price of $42.19 sits near the lower end of its 52-week range, at approximately 3.6% above the 52-week low of $36.61, indicating that the stock is trading near its lows, which could signal either a value opportunity or a falling knife. The stock's beta of 1.201 suggests it is 20% more volatile than the market, amplifying both downside and upside moves.
Beta
1.20
1.20x market volatility
Max Drawdown
-78.8%
Largest decline past year
52-Week Range
$37-$194
Price range past year
Annual Return
-39.0%
Cumulative gain past year
| Period | OKLO Return | S&P 500 |
|---|---|---|
| 1m | +2.4% | +2.4% |
| 3m | -33.2% | +4.6% |
| 6m | -31.9% | +11.7% |
| 1y | -39.0% | +21.4% |
| ytd | -37.8% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OKLO Fundamental Analysis
Oklo is a pre-revenue company, with zero revenue reported in the most recent quarter (Q1 2026) and all historical quarters, so the revenue trajectory is non-existent, and the company is entirely dependent on future commercialization. The net loss in Q1 2026 was -$33.06 million, a significant increase from the -$9.81 million loss in Q1 2025, indicating that operating expenses are growing as the company invests in R&D and regulatory efforts. The gross margin is 0% due to no revenue, and the company's operating margin is also 0%, as it has no sales to cover its costs. The company's balance sheet is strong in terms of liquidity, with a current ratio of 49.08 and cash of $1.59 billion at the end of Q1 2026, but it is burning cash with negative free cash flow of -$50.68 million in Q1 2026, and it relies on external financing, as evidenced by $1.18 billion in common stock issued in the same quarter. The debt-to-equity ratio is minimal at 0.00098, indicating negligible debt, but the company's ROE is -7.16%, reflecting the losses.
Quarterly Revenue
$0.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-153481000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OKLO Overvalued?
Given that Oklo has negative net income and EBITDA, the appropriate valuation metric is the price-to-sales ratio, but since the company has zero revenue, the PS ratio is undefined (0), making traditional valuation metrics inapplicable. Instead, we must rely on other metrics like price-to-book (PB) ratio, which is 7.11, indicating the market is valuing the company at a significant premium to its book value, reflecting expectations of future growth. The forward PE ratio is -50.01, which is negative due to expected losses, and the EV/EBITDA is -88.59, also negative, confirming the company's unprofitability. Compared to the industry, Oklo's valuation is extreme, with a PB ratio of 7.11 versus a typical utility sector average of around 1-2x, representing a substantial premium that is not justified by current fundamentals but rather by the potential for disruptive nuclear technology. Historically, the PB ratio has ranged from as low as 1.92 in early 2023 to as high as 150.54 in late 2021, and the current 7.11 is in the middle of that range, suggesting that while the stock has de-rated significantly from its peak, it still trades at a level that prices in optimistic long-term scenarios.
PE
-99.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-88.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial. Oklo has no revenue, and its net loss widened to -$33.06M in Q1 2026 from -$9.81M a year earlier, reflecting escalating R&D and G&A expenses. The company burned -$50.68M in free cash flow in Q1, and while it holds $1.59B in cash, the reliance on external financing is evident from the $1.18B stock issuance in the same quarter. This dilution, combined with a negative ROE of -7.16%, indicates that the company is consuming capital without generating returns, and the current cash runway, while long, is finite and dependent on continued investor appetite for speculative nuclear plays.
FAQ
The key risks are: 1) Financial risk: zero revenue and a net loss of -$33.06M in Q1 2026, with negative free cash flow of -$50.68M, requiring constant external financing and causing dilution. 2) Regulatory risk: the NRC approval process is lengthy and uncertain, and any delays could push commercialization further out. 3) Market risk: the stock has a beta of 1.201, making it 20% more volatile than the market, and it has already fallen 49% in the past year. 4) Execution risk: the company has no concrete customer orders, and the technology is unproven at commercial scale. The most severe risk is a combination of regulatory failure and cash depletion, which could lead to a decline toward the analyst low target of $14.
The 12-month forecast is highly uncertain, with a wide range of outcomes. The bull case (25% probability) targets $84.20 to $130, driven by successful commercialization and regulatory wins. The base case (50% probability) targets $42.19 to $84.20, assuming steady progress but no revenue. The bear case (25% probability) targets $14 to $36.61, if regulatory setbacks or funding issues arise. The most likely scenario is the base case, with the stock trading near the analyst average of $84.20, but the key assumption is that Oklo continues to make progress without major setbacks. Investors should monitor regulatory approvals and customer announcements closely.
OKLO is significantly overvalued based on traditional metrics. With zero revenue, the price-to-sales ratio is undefined, and the price-to-book ratio of 7.11 is far above the utility sector average of 1-2x. The forward PE is negative at -50.01, reflecting expected losses. Historically, the PB ratio has ranged from 1.92 to 150.54, and the current 7.11 is in the middle, suggesting the market is pricing in substantial future growth. This valuation implies that investors expect Oklo to successfully commercialize its reactors and generate significant revenue, which is highly uncertain. Therefore, the stock is overvalued relative to current fundamentals, but the premium may be justified if the technology succeeds.
OKLO is a high-risk, high-reward speculative stock. Analysts are bullish with a Buy rating and an average target of $84.20, implying ~99.6% upside from the current price of $42.19. However, the company has zero revenue, widening losses, and trades at a price-to-book ratio of 7.11, far above the utility sector average of 1-2x. The biggest downside risk is a decline to the 52-week low of $36.61, a -13% loss, or worse to the analyst low target of $14, a -67% loss. It could be a good buy for investors who believe in the long-term nuclear story and can tolerate extreme volatility, but it is not suitable for risk-averse investors.
OKLO is more suitable for long-term investment, given its pre-revenue stage and the multi-year timeline to commercialization. The stock is highly volatile, with a beta of 1.201 and a 49% decline over the past year, making it risky for short-term trading. The company has a strong cash position of $1.59B, providing a runway of several years, but the path to profitability is long. Investors should have a minimum holding period of 3-5 years to allow for regulatory approvals and potential revenue generation. Short-term traders may find opportunities in news-driven swings, but the risk of significant losses is high. For long-term investors, the potential upside is substantial if Oklo succeeds, but the risk of total loss is also real.